Federally Funded Consortia

The Collaborative Pediatric Critical Care Research Network (CPCCRN) network consists of seven clinical sites and a data coordinating center, funded by the National Institutes of Health to investigate the safety and efficacy of treatments, management strategies and outcomes of critically ill children in intensive care units and rare diseases. The CPCCRN has completed observational studies on issues related to critical illness that includes asthma and infections. The Hepato-Renal Fibrocystic Disease (HFRRD) Translational Core Center focuses on rare recessive disorders and studies interventions to reduce pathologic grief in parents after the death of a critically ill child. The Center for Translational Science, together with the clinical division of Emergency Medicine and Trauma Services, leads Improving Pediatric Asthma Care in the District of Columbia (IMPACT DC), an award-winning community-based intervention. Federally funded research includes the Pediatric Applied Research Network (PECARN), which includes pediatric emergency care providers, and The Rare Diseases Clinical Research Center (RDCRC) on Urea Cycle Disorders (UCDC).

The Collaborative Pediatric Critical Care Research Network CPCCRN

This network was initially funded by the National Institutes of Health in 2005 to investigate the safety and efficacy of treatments, management strategies and outcomes of critically ill children in intensive care units. The network consists of seven clinical sites and a data coordinating center.

Hepato Renal Fibrocystic Disease Core Center HRFDCC

The Hepato-Renal Fibrocystic Disease (HFRD) Translational Core Center was founded in 2005 by Lisa Guay-Woodford, MD, during her tenure at the University of Alabama at Birmingham and funded through an National Institutes of Health P30 mechanism. Autosomal recessive polycystic kidney disease (ARPKD) and other hepato-renal fibrocystic diseases are relatively rare recessive disorders, but constitute an important set of childhood nephropathies.

Improving Pediatric Asthma Care in the District of Columbia IMPACT DC

The Center for Translational Science, together with the clinical division of Emergency Medicine and Trauma Services, leads Improving Pediatric Asthma Care in the District of Columbia (IMPACT DC), an award-winning community-based intervention. Our team uses an acute asthma attack leading to an emergency department visit as a “teachable moment” to help patients and families think of asthma as a chronic disease that requires daily maintenance rather than a series of unrelated attacks requiring emergency care. 

Inner City Asthma Consortium ICAC

Children’s National is one of only 10 sites nationwide that are part of the National Institute of Allergy and Infectious Diseases funded Inner City Asthma Consortium (ICAC). The ICAC studies monitoring and immune-based treatments with the potential to help inner city and disadvantaged children with asthma. 

Pediatric Clinical Pharmacology Research Program

Children’s National is one of only four sites nationwide that are part of the Eunice Shriver Kennedy National Institute of Child Health and Development funded Research Centers in Pediatric Developmental Pharmacology.